Pneumococcal Conjugate Vaccine for stem cell transplant recipients 2022-2024 (2024-2025, 2025-2026)

Hanke lühikirjeldus

The Ministry of Social Affairs and Health (hereinafter ”STM”) and Finnish Institute for Health and Welfare (hereinafter "THL" or “Customer” ) request your tender for Pneumococcal conjugate Vaccine for stem cell transplant recipients belonging to the National Vaccination Programme in Finland. The contract period is about two years 2022-2024. The procurement contains two options to extend the contract for the periods 2024-2025 and 2025-2026. Estimated quantity for the contract period including option is 5000 doses. Customer reserves the right to increase or decrease the ordered numbers of doses by up to 20%. The contract will be awarded to one Supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition. Please note that all times given in the Call for tender refer to local time in Finland. Tender annexes: Annex 1 Contract Annex 2 JYSE 2014 Supplies (Updated April 2017) Annex 3 Handi